Rhythm Biosciences Requests Trading Halt for Capital Raise
Key points
- Rhythm Biosciences requests trading halt pending announcement on capital raise
- Trading halt to remain in place until earlier of market open on 18 August or announcement release
- Company not aware of any other information required to inform the market
Full summary
Rhythm Biosciences Limited (ASX: RHY) has requested a trading halt in its securities pending an announcement by the company in relation to a capital raise. The company has requested that trading in its securities be halted until after the expected announcement is made or until the market opens on Monday, 18 August 2025, whichever is the earlier. Rhythm Biosciences has stated that it is not aware of any reason why this trading halt request should not be granted or of any other information necessary to inform the market about the trading halt. The company has requested the trading halt in accordance with ASX Listing Rule 17.1.
Summary generated by a large language model. Please interpret with care.